FFA
LUCD icon

Farther Finance Advisors’s Lucid Diagnostics LUCD Stock Holding History

Farther Finance Advisors’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256 Buy
241
+224
+1,318% +$241 ﹤0.01% 5676
2026
Q1 		$20 Buy
+17
New +$22 ﹤0.01% 5652

Other funds holding LUCD

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.37B AUM 28.49% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.15B AUM 70.1% 1-Year Est. Return
AAG
Accordant Advisory Group Annapolis, Maryland $148M AUM 23.8% 1-Year Est. Return

Farther Finance Advisors's LUCD Position: Q2 2026 in Review

Farther Finance Advisors increased its Lucid Diagnostics (LUCD) stake by 1,318% in Q2 2026, buying an estimated $241 and bringing the position to 241 shares worth $256. The position accounts for ﹤0.01% of the portfolio, ranked #5676.

Farther Finance Advisors first reported a position in LUCD in Q1 2026 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Farther Finance Advisors held 241 shares of Lucid Diagnostics worth $256 as of Q2 2026.
  • Farther Finance Advisors bought 224 Lucid Diagnostics shares in Q2 2026, an estimated $241.
  • Lucid Diagnostics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5676 holding.
  • Farther Finance Advisors first reported a position in Lucid Diagnostics in Q1 2026 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.